Pedro A. Andrade Filho

Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen–Specific T-cell Immunity in Head and Neck Cancer Patients

Steve Lee, Pedro A. Andrade Filho, Christopher A. Lord et al. · Clinical Cancer Research · 2013 · 312 citations · Full text

Life Sciences, Immunology, Oncology +17

Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers

Regiane S. Andrade, Dwight E. Heron, Berna Değirmenci et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 186 citations

Medicine, Nuclear Medicine, Radiology +16

Immunization With Analog Peptide in Combination With CpG and Montanide Expands Tumor Antigen-specific CD8+ T Cells in Melanoma Patients

Julien Fourcade, Pavol Kudela, Pedro A. Andrade Filho et al. · Journal of Immunotherapy · 2008 · 106 citations

Medicine, Immunology, Oncology +17

Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes

Michael S. Leibowitz, Pedro A. Andrade Filho, Soldano Ferrone et al. · Cancer Immunology Immunotherapy · 2011 · 99 citations

Life Sciences, Immunology, Oncology +10

Insights from Studies with Oral Cleft Genes Suggest Associations between WNT-pathway Genes and Risk of Oral Cancer

Pedro A. Andrade Filho, Ariadne Letra, Angela Cramer et al. · Journal of Dental Research · 2011 · 92 citations · Full text

Medicine, Oncology, Oral Pathology +15